EGF and cancer: Since core-fucosylation regulates cell surface glycoproteins such as epidermal growth factor and transforming growth factor beta receptors directly [42,43], and loss of fucosylation brings dramatic changes in TRAIL signaling as described above, fucosylation is a promising target for cancer diagnosis and therapeutics.